First Trust Advisors LP Novo Cure LTD Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $4.59 Million - $6.13 Million	71,782 Added 1046.84%	78,639 $5.77 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $466,207 - $614,181	6,857 New	6,857 $521,000
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $1.65 Million - $2.32 Million	-27,455 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $15.9 Million - $25.9 Million	-211,948 Reduced 88.53%	27,455 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $18.2 Million - $30.5 Million	156,541 Added 188.92%	239,403 $27.8 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $14.6 Million - $25.2 Million	-111,914 Reduced 57.46%	82,862 $18.4 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $9.15 Million - $14 Million	-73,732 Reduced 27.46%	194,776 $25.7 Million
Q4 2020 Feb 02, 2021	BUY	$112.16 - $174.14 $30.1 Million - $46.8 Million	268,508 New	268,508 $46.5 Million
Q3 2020 Nov 05, 2020	SELL	$58.05 - $111.31 $2.54 Million - $4.87 Million	-43,744 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$57.2 - $74.41 $1.27 Million - $1.66 Million	-22,248 Reduced 33.71%	43,744 $2.59 Million
Q1 2020 May 06, 2020	SELL	$57.05 - $95.75 $597,427 - $1 Million	-10,472 Reduced 13.7%	65,992 $4.44 Million
Q4 2019 Feb 03, 2020	SELL	$68.3 - $93.8 $1.06 Million - $1.46 Million	-15,520 Reduced 16.87%	76,464 $6.44 Million
Q3 2019 Nov 04, 2019	SELL	$61.86 - $97.8 $306,763 - $484,990	-4,959 Reduced 5.12%	91,984 $6.88 Million
Q2 2019 Jul 30, 2019	SELL	$42.22 - $63.23 $87,395 - $130,886	-2,070 Reduced 2.09%	96,943 $6.13 Million
Q1 2019 May 09, 2019	SELL	$31.96 - $56.12 $272,714 - $478,871	-8,533 Reduced 7.93%	99,013 $4.77 Million
Q4 2018 Feb 07, 2019	SELL	$28.72 - $52.63 $1.94 Million - $3.56 Million	-67,662 Reduced 38.62%	107,546 $3.6 Million
Q3 2018 Oct 25, 2018	BUY	$32.0 - $52.4 $1.04 Million - $1.71 Million	32,543 Added 22.81%	175,208 $9.18 Million
Q2 2018 Aug 02, 2018	BUY	$19.85 - $32.0 $562,568 - $906,912	28,341 Added 24.79%	142,665 $4.47 Million
Q1 2018 Apr 23, 2018	SELL	$19.3 - $23.65 $575,738 - $705,503	-29,831 Reduced 20.69%	114,324 $2.49 Million
Q4 2017 Feb 08, 2018	BUY	$16.3 - $21.9 $2.35 Million - $3.16 Million	144,155	144,155 $2.91 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$351 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$342 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$229 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$125 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$87.6 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account